Substance abuse and movement disorders
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus‐dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders. © 2010 Movement Disorder Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some of the substances reported to potentially worsen tics include stimulants, selective serotonin reuptake inhibitors (SSRIs), lamotrigine, and cocaine.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818 · cited 1×
“39 for current smokers.(158) Dose-dependent protection holds for both men and women.”
BackgroundInfluence of alcohol on gait in patients with essential tremor
Klebe, S., Stolze, H., Grensing, K., Volkmann, J., Wenzelburger, R., & Deuschl, G. (2005) · Neurology · doi:10.1212/01.wnl.0000167550.97413.1f · Cited by 99 · cited 1×
“Independent of leg tremor, patients with advanced essential tremor often have ataxic gait, which also improves with ethanol ingestion.(27) Ethanol is believed to dampen tremor by its actions at olivocerebellar circuits.”
Background
Research works printed but not linked: 174
- Brust JCM, 2004, Neurological aspects of substance abuse, 334
- 10.1212/WNL.40.5.741 · DOI
- 10.1136/jnnp.28.6.529 · DOI
- LeFebvre‐D'Amour M, 1978, Tremor in alcoholic patients, Prog Clin Neurophysiol, 6, 160
- 10.1212/WNL.35.11.1660 · DOI · Paper page
- 10.1056/NEJM198510103131501 · DOI · Paper page
- 10.1016/S0140-6736(89)90842-8 · DOI · Paper page
- Kominger C, 2003, Gamma‐hydroxybutyric acid in the treatment of alcohol withdrawal syndrome in patients admitted to hospital, Acta Med Austriaca, 30, 83
- 10.1016/S0733-8619(18)30143-9 · DOI
- 10.1001/archneur.1992.00530310088016 · DOI
- 10.1002/ana.410090117 · DOI
- 10.1002/ana.410120307 · doi:10.1002/ana.410120307
- 10.1111/j.1360-0443.1988.tb00492.x · doi:10.1111/j.1360-0443.1988.tb00492.x
- Shen WW, 1984, Extrapyramidal symptoms associated with alcohol withdrawal, Biol Psychiatry, 19, 1037
- 10.1002/mds.870050109 · doi:10.1002/mds.870050109
- Fornazzari L, 1982, Transient choreiform dyskinesias during alcohol withdrawal, Can J Neurol Sci, 9, 89, 10.1017/S0317167100043742 · DOI
- 10.1136/bmj.4.5730.278 · doi:10.1136/bmj.4.5730.278
- 10.1111/j.1471-4159.1977.tb06522.x · DOI
- 10.1007/BF00431699 · DOI
- Lutz EG, 1976, Neuroleptic‐induced akathesia and dystonia triggered by alcohol, JAMA, 236, 2422, 10.1001/jama.1976.03270220042034 · DOI
- 10.3109/00952999009001572 · DOI
- 10.1097/00007611-198308000-00028 · DOI
- Adams RD, 1953, The neurological disorder associated with liver disease, Res Publ Assoc Res Nerv Ment Dis, 32, 198
- 10.1136/jnnp.45.9.857-a · doi:10.1136/jnnp.45.9.857-a
- Basile AS, 1991, The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine ligands, Pharmacol Rev, 43, 27, 10.1016/S0031-6997(25)06659-1 · DOI
- 10.1023/A:1011658311004 · doi:10.1023/a:1011658311004
- 10.1139/y82-082 · DOI
- 10.1002/ana.410390515 · DOI · Paper page
- 10.1002/mds.10553 · DOI
- 10.1212/WNL.33.8.1074 · DOI · Paper page
- 10.1176/ajp.139.11.1471 · DOI
- 10.1002/mds.20230 · DOI
- 10.1212/WNL.59.8.1187 · DOI
- 10.1212/01.WNL.0000073142.40185.C1 · doi:10.1212/01.wnl.0000073142.40185.c1
- 10.1212/WNL.56.9.1213 · doi:10.1212/wnl.56.9.1213
- 10.1007/s100720070053 · doi:10.1007/s100720070053
- 10.1212/WNL.58.2.242 · DOI
- 10.1002/mds.20452 · doi:10.1002/mds.20452
- 10.1002/mds.870110629 · doi:10.1002/mds.870110629
- 10.1002/mds.20150 · doi:10.1002/mds.20150
- 10.1007/s004150050116 · doi:10.1007/s004150050116
- 10.1111/j.1528-1157.1996.tb00579.x · DOI
- 10.1024/0040-5930.57.4.241 · DOI
- 10.1007/s00406-002-0371-8 · DOI
- 10.1002/mds.10363 · doi:10.1002/mds.10363
- 10.1002/ana.410020405 · doi:10.1002/ana.410020405
- 10.1001/jama.1976.03270220042034 · DOI
- 10.5694/j.1326-5377.1981.tb132069.x · doi:10.5694/j.1326-5377.1981.tb132069.x
- 10.1136/jnnp.65.3.370 · doi:10.1136/jnnp.65.3.370
- Gallinberti L, 2000, Gamma‐hydroxybutyric acid in the treatment of alcohol and heroin dependence, Alcohol, 20, 257, 10.1016/S0741-8329(99)00089-0 · DOI
- 10.1002/mds.20605 · DOI
- 10.1016/S0736-4679(99)00163-8 · DOI
- 10.1097/00004311-196900710-00007 · DOI
- 10.7326/0003-4819-90-3-361 · DOI
- 10.1176/appi.ajp.158.8.1330-a · DOI
- 10.1016/S0379-0738(99)00040-7 · DOI
- 10.1016/S0303-8467(97)00088-7 · DOI
- 10.1046/j.1360-0443.1999.94343113.x · doi:10.1046/j.1360-0443.1999.94343113.x
- Miller JM, 2006, Anhedonia after a selective bilateral lesion of the globus pallidus, Am J Psychiatry, 163, 786, 10.1176/ajp.2006.163.5.786 · DOI
- 10.1097/00002826-199903000-00004 · doi:10.1097/00002826-199903000-00004
- 10.1007/s00415-005-0760-9 · doi:10.1007/s00415-005-0760-9
- 10.1136/bmj.299.6692.150 · DOI
- 10.7326/0003-4819-98-4-548 · doi:10.7326/0003-4819-98-4-548
- 10.1002/ana.410140520 · doi:10.1002/ana.410140520
- 10.1002/ana.410130213 · DOI · Paper page
- 10.1097/00004714-198109000-00009 · doi:10.1097/00004714-198109000-00009
- 10.1345/aph.1C091 · DOI
- 10.1097/00000542-200306000-00033 · DOI
- 10.1097/00045391-200201000-00010 · DOI · Paper page
- 10.1007/BF03020183 · DOI
- 10.1212/WNL.32.6.623 · doi:10.1212/wnl.32.6.623
- 10.2165/00003495-198326010-00004 · DOI
- 10.1056/NEJM198502213120809 · doi:10.1056/nejm198502213120809
- 10.1176/appi.neuropsych.15.1.116 · doi:10.1176/appi.neuropsych.15.1.116
- 10.1001/archneur.1980.00500600075016 · doi:10.1001/archneur.1980.00500600075016
- 10.1055/s-2007-979316 · doi:10.1055/s-2007-979316
- 10.1001/archneur.1981.00510110097023 · doi:10.1001/archneur.1981.00510110097023
- 10.1159/000117618 · doi:10.1159/000117618
- 10.1016/S0095-5108(18)30081-2 · DOI
- 10.1126/science.6823561 · DOI · Paper page
- 10.1212/WNL.35.7.949 · DOI · Paper page
- 10.1038/317246a0 · DOI · Paper page
- 10.1016/0306-4522(91)90180-V · DOI · Paper page
- 10.1016/S1566-2772(01)00019-6 · DOI · Paper page
- 10.1002/ana.10191 · DOI · Paper page
- 10.1016/S0140-6736(82)90101-5 · DOI · Paper page
- 10.1007/s003300050467 · doi:10.1007/s003300050467
- 10.1212/WNL.53.8.1765 · DOI
- 10.1259/bjr/61535842 · DOI
- 10.1002/mds.20158 · doi:10.1002/mds.20158
- 10.1016/j.crad.2007.07.021 · DOI
- 10.1007/s004150050469 · doi:10.1007/s004150050469
- 10.1016/0140-6736(92)92268-K · doi:10.1016/0140-6736(92)92268-k
- 10.1038/sj.mp.4000575 · DOI
- 10.1007/BF00404607 · DOI · Paper page
- 10.1136/jnnp.44.8.728 · doi:10.1136/jnnp.44.8.728
- 10.1016/0735-6757(88)90050-2 · DOI
- 10.1034/j.1600-0404.2003.02086.x · doi:10.1034/j.1600-0404.2003.02086.x
- 10.1212/WNL.24.4.312 · DOI
- 10.1007/BF00414035 · DOI
- 10.1111/j.1469-8749.1974.tb02715.x · DOI · Paper page
- 10.1001/archneur.1977.00500220064011 · DOI · Paper page
- 10.1192/bjp.143.3.300 · DOI
- 10.1056/NEJM196806202782502 · DOI · Paper page
- 10.1254/jphs.92.178 · DOI · Paper page
- 10.1093/brain/awh046 · DOI · Paper page
- 10.1056/NEJMoa072488 · DOI · Paper page
- Rylander G, 1972, Psychosis and the punding and choreiform syndromes in addictions to central stimulant drugs, Psychiatry Neurol Neurochir, 75, 203
- 10.1212/WNL.44.4.751 · doi:10.1212/wnl.44.4.751
- 10.1016/S0006-3223(98)00238-8 · doi:10.1016/s0006-3223(98)00238-8
- 10.1136/jnnp.52.12.1447-a · doi:10.1136/jnnp.52.12.1447-a
- 10.1016/0376-8716(93)90010-N · DOI
- 10.1016/S0196-0644(89)80111-8 · DOI
- 10.1016/0002-9343(90)90484-U · DOI · Paper page
- Rebischung D, 1990, Dystonic movements associated with cocaine use, Ann Neurol, 28, 267
- 10.1212/WNL.40.5.863 · doi:10.1212/wnl.40.5.863
- 10.1016/S0196-0644(05)80951-5 · doi:10.1016/s0196-0644(05)80951-5
- 10.1212/WNL.39.7.996-a · DOI
- 10.1097/00007611-199710000-00017 · doi:10.1097/00007611-199710000-00017
- 10.1016/S0735-6757(97)90198-4 · doi:10.1016/s0735-6757(97)90198-4
- 10.1212/WNL.56.7.964 · doi:10.1212/wnl.56.7.964
- 10.1212/WNL.41.10.1670 · DOI
- 10.1016/S0140-6736(86)91478-9 · DOI
- 10.1056/NEJM198608073150616 · DOI
- 10.1212/WNL.40.6.999 · doi:10.1212/wnl.40.6.999
- 10.1002/ana.410230431 · DOI
- 10.1111/j.1530-0277.1996.tb01111.x · DOI
- 10.1001/jama.258.6.780 · DOI
- 10.1080/02791072.1986.10472367 · DOI
- Kalant H, 2001, The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs, Can Med Assoc J, 165, 917
- 10.1007/s001340050920 · doi:10.1007/s001340050920
- 10.1007/s00101-002-0433-3 · doi:10.1007/s00101-002-0433-3
- Battaglia G, 1987, 3,4‐Methylenedioxymethamphetamine and 3,4‐methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine‐labelled serotonin uptake sites, J Pharmacol Exp Ther, 242, 911, 10.1016/S0022-3565(25)39191-3 · DOI · Paper page
- Ricaurte GA, 1988, 3,4‐Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates, JAMA, 260, 51, 10.1001/jama.1988.03410010059035 · DOI · Paper page
- 10.1056/NEJM199905063401817 · doi:10.1056/nejm199905063401817
- 10.1056/NEJMc030208 · doi:10.1056/nejmc030208
- 10.1002/mds.10623 · DOI
- 10.1002/mds.10643 · DOI
- 10.1126/science.1074501 · DOI · Paper page
- 10.1126/science.301.5639.1454b · doi:10.1126/science.301.5639.1454b
- 10.1523/JNEUROSCI.23-27-09107.2003 · DOI · Paper page
- 10.1007/BF00421258 · DOI
- 10.1007/s002130050848 · DOI · Paper page
- 10.1159/000112901 · DOI · Paper page
- 10.1002/ana.410130616 · DOI · Paper page
- 10.1007/BF00314410 · DOI
- 10.1212/01.WNL.0000118203.67138.3E · DOI · Paper page
- 10.1007/BF00408109 · DOI
- 10.1080/105504901750160529 · DOI · Paper page
- 10.1111/j.1360-0443.1984.tb00267.x · doi:10.1111/j.1360-0443.1984.tb00267.x
- 10.1212/WNL.33.10.1337 · DOI
- 10.1093/qjmed/93.10.655 · DOI
- 10.1093/brain/121.10.1903 · DOI
- 10.1016/S0196-0644(81)80047-9 · DOI · Paper page
- 10.1016/0149-7634(84)90006-X · doi:10.1016/0149-7634(84)90006-x
- Salomon ME, 1998, Goldfrank's toxicologic emergencies, 1145
- 10.1002/ana.10028 · DOI · Paper page
- 10.1002/ana.10315 · DOI
- 10.1212/WNL.58.4.581 · DOI · Paper page
- 10.1212/WNL.52.1.115 · DOI · Paper page
- 10.1016/S0161-813X(02)00036-0 · DOI
- 10.1212/WNL.57.6.1032 · DOI
- 10.1038/379733a0 · DOI · Paper page
- 10.1212/WNL.58.9.1381 · DOI
- 10.1212/WNL.50.5.1458 · DOI
- 10.1016/0006-8993(94)91593-8 · DOI
- 10.1046/j.1471-4159.1998.71062439.x · DOI · Paper page
- 10.1016/0024-3205(94)00839-6 · DOI
- 10.1002/1531-8257(200009)15:5<1014::AID-MDS1041>3.0.CO;2-O · doi:10.1002/1531-8257(200009)15:5<1014::aid-mds1041>3.0.co;2-o
- 10.1016/S1474-4422(03)00529-5 · DOI · Paper page
- 10.1002/mds.20045 · DOI · Paper page
- 10.1097/00002826-200105000-00009 · DOI · Paper page
- 10.1212/01.wnl.0000184487.72289.f0 · DOI · Paper page
- Weed MR, 1995, The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys, J Pharmacol Exp Ther, 275, 1367, 10.1016/S0022-3565(25)12193-9 · DOI · Paper page
Cited by
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
The Hotel Study: Multimorbidity in a Community Sample Living in Marginal Housing
Vila-Rodriguez, F., Panenka, W. J., Lang, D. J., Thornton, A. E., Vertinsky, T., Wong, H., Barr, A. M., Procyshyn, R. M., Sidhu, J. J., Smith, G. N., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12111439 · Cited by 94
Becker, J. A. J., Kieffer, B. L., & Le Merrer, J. (2017) · Addiction Biology · doi:10.1111/adb.12405 · Cited by 77
Metadata
- Authors
- Brust, J. C. M.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2010-08-18
- Volume
- 25
- Issue
- 13
- Pages
- 2010-2020
- ISSN
- 0885-3185
- 1531-8257
- Cited by
- 57
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Substance abuse and movement disorders. https://app.cochat.ai/papers/10.1002/mds.22599
- The paper
- Brust, J. C. M. (2010). Substance abuse and movement disorders. Movement Disorders. https://doi.org/10.1002/mds.22599
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.